Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis

S Kaptoge, SRK Seshasai, P Gao… - European heart …, 2014 - academic.oup.com
Aims Because low-grade inflammation may play a role in the pathogenesis of coronary heart
disease (CHD), and pro-inflammatory cytokines govern inflammatory cascades, this study …

Inflammatory markers and onset of cardiovascular events: results from the Health ABC study

M Cesari, BWJH Penninx, AB Newman… - Circulation, 2003 - Am Heart Assoc
Background—Inflammation plays an important role in cardiovascular disease. The aim of
this study is to investigate the predictive value of several inflammatory markers on the …

Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective

PWF Wilson - The American journal of medicine, 2008 - Elsevier
A growing body of evidence indicates that patients with immune-inflammatory diseases
experience an increased risk for cardiovascular morbidity and mortality. However, patients …

Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the Prevention of atherothrombosis: inflammation and anti …

DM Moreira, RL da Silva, JL Vieira, T Fattah… - American Journal of …, 2015 - Springer
Coronary artery disease (CAD) and acute myocardial infarction (AMI) are inflammatory
pathologies, involving interleukins (ILs), such as IL-1β, IL-6 and tumor necrosis factor (TNF) …

[HTML][HTML] Inflammatory biomarkers in coronary artery disease

E Zakynthinos, N Pappa - Journal of cardiology, 2009 - Elsevier
Current evidence supports that inflammation is a major driving force underlying the initiation
of coronary plaques, their unstable progression, and eventual disruption; patients with a …

Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis

Y Liu, S Guan, H Xu, N Zhang, M Huang… - Frontiers in …, 2023 - frontiersin.org
Background Inflammation is a risk factor for cardiovascular disease (CVD), and particular
inflammatory parameters can be used to predict the incidence of CVD. The aim of this study …

Inflammatory cytokines and cardiovascular disease

T Ito, U Ikeda - Current Drug Targets-Inflammation & Allergy, 2003 - ingentaconnect.com
The designation of atherosclerosis as a chronic inflammatory process represents an
interesting paradigmatic shift for cardiologists. The plasma concentrations of interleukin-6 …

Inflammatory markers and the risk of coronary heart disease in men and women

JK Pai, T Pischon, J Ma, JAE Manson… - … England Journal of …, 2004 - Mass Medical Soc
Background Few studies have simultaneously investigated the role of soluble tumor
necrosis factor α (TNF-α) receptors types 1 and 2 (sTNF-R1 and sTNF-R2), C-reactive …

Inflammatory markers and coronary heart disease

N Rifai, PM Ridker - Current opinion in lipidology, 2002 - journals.lww.com
Inflammatory markers and coronary heart disease : Current Opinion in Lipidology Inflammatory
markers and coronary heart disease : Current Opinion in Lipidology Log in or Register …

Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses …

PM Ridker, JG MacFadyen, RJ Glynn… - European heart …, 2020 - academic.oup.com
Aims In epidemiologic cohorts initiated> 30 years ago, inflammatory biomarkers, such as
interleukin-6 (IL-6) and high-sensitivity C-reactive protein (hsCRP) were shown to …